Laura Rusconi
Varese, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo.
Journal: Neurobiology of disease
Published: August 27, 2019
Pregnenolone and pregnenolone-methyl-ether rescue neuronal defects caused by dysfunctional CLIP170 in a neuronal model of CDKL5 Deficiency Disorder.
Journal: Neuropharmacology
Published: June 20, 2019
Rescue of prepulse inhibition deficit and brain mitochondrial dysfunction by pharmacological stimulation of the central serotonin receptor 7 in a mouse model of CDKL5 Deficiency Disorder.
Journal: Neuropharmacology
Published: July 13, 2018
The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5.
Journal: Human molecular genetics
Published: February 21, 2018
CDKL5 and Shootin1 Interact and Concur in Regulating Neuronal Polarization.
Journal: PloS one
Published: March 08, 2015
Synaptic synthesis, dephosphorylation, and degradation: a novel paradigm for an activity-dependent neuronal control of CDKL5.
Journal: The Journal of biological chemistry
Published: January 04, 2015
MeCP2 post-translational modifications: a mechanism to control its involvement in synaptic plasticity and homeostasis?
Journal: Frontiers in cellular neuroscience
Published: May 13, 2014
What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy.
Journal: Neural plasticity
Published: February 16, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026